FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Sandoz Dicloxacillin Sodium Capsules Recall

Dicloxacillin Sodium Capsules, USP 250mg, Rx Only, 100 Capsule Bottle, Manufactured in…

Sandoz, Inc · Princeton, NJ

Risk level
Class III
Reported by FDA
Jun 29, 2016
Recall ID
D-1045-2016
Check your lot numberHow we source this data

Summary

Sandoz recalled Dicloxacillin Sodium Capsules starting May 2, 2016. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1045-2016 on Jun 29, 2016. Reason: Failed Impurities/Degradation Specifications:Out of specification result for a known impurity obtained during testing. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications:Out of specification result for a known impurity obtained during testing.

Product description

Dicloxacillin Sodium Capsules, USP 250mg, Rx Only, 100 Capsule Bottle, Manufactured in Austria by Sandoz Gmbh, Distributed by Sandoz Inc., Princeton, NJ 08540, Product of Spain, NDC 0781-2248-01

Lot numbers, UPCs & expiration codes

Lot #s: EN3846, Exp 08/2016; FA4809, Exp 2/2017, FW3654 , Exp11/2017

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1045-2016
Classification
Class III
Status
Terminated
Recall initiated
May 2, 2016
FDA report date
Jun 29, 2016
Quantity
78,606 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Sandoz, Inc

Original FDA data

Every field from FDA enforcement report D-1045-2016, exactly as published.

Show all FDA fields
City
Princeton
State
NJ
Status
Terminated
Country
United States
Event ID
74068
Address
506 Carnegie Ctr Ste 400
Code information
Lot #s: EN3846, Exp 08/2016; FA4809, Exp 2/2017, FW3654 , Exp11/2017
Postal code
08540-6243
Report date
Jun 29, 2016
Product type
Drugs
Recall number
D-1045-2016
Classification
Class III
Recalling firm
Sandoz, Inc
Product quantity
78,606 bottles
Termination date
Aug 17, 2017
Reason for recall
Failed Impurities/Degradation Specifications:Out of specification result for a known impurity obtained during testing.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Dicloxacillin Sodium Capsules, USP 250mg, Rx Only, 100 Capsule Bottle, Manufactured in Austria by Sandoz Gmbh, Distributed by Sandoz Inc., Princeton, NJ 08540, Product of Spain, NDC 0781-2248-01
Distribution pattern
Nationwide
Recall initiation date
May 2, 2016
Initial firm notification
Letter
Center classification date
Jun 20, 2016

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1045-2016, published Jun 29, 2016. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls